IP Group (IPO) RNS Announcements

Add to Alert list
Date Time Source Announcement
10 Sep 2021 05:21 PM
RNS
Holding(s) in Company
08 Sep 2021 10:53 AM
RNS
Director/PDMR Shareholding, SAYE scheme
19 Aug 2021 10:41 AM
RNS
Scrip Dividend Reference Price
12 Aug 2021 05:05 PM
RNS
Director Declaration
05 Aug 2021 07:00 AM
RNS
Half-yearly results
27 Jul 2021 07:03 AM
RNS
Portfolio company Artios Pharma raises $153m
22 Jul 2021 11:30 AM
RNS
Notice of Results
01 Jul 2021 07:00 AM
RNS
Total Voting Rights
28 Jun 2021 07:30 AM
RNS
Director/PDMR Shareholding
18 Jun 2021 09:52 AM
RNS
Director/PDMR Shareholding
17 Jun 2021 07:00 AM
RNS
Portfolio company Apollo Therapeutics raises $145m
15 Jun 2021 08:00 AM
RNS
Further re Scrip Dividend
09 Jun 2021 11:29 AM
RNS
Result of AGM
09 Jun 2021 07:00 AM
RNS
AGM Statement
07 Jun 2021 07:00 AM
RNS
Portfolio co Iksuda completes $42m financing round
28 May 2021 03:36 PM
RNS
Director/PDMR Shareholding
28 May 2021 10:00 AM
RNS
Joint venture with China Everbright to launch fund
27 May 2021 07:00 AM
RNS
Portfolio co Pulmocide completes $92m Series C
26 May 2021 02:44 PM
RNS
Update on AGM
20 May 2021 10:01 AM
RNS
Scrip Dividend Reference Price
17 May 2021 12:44 PM
RNS
Additional fair value gain of £20m
10 May 2021 11:15 AM
RNS
Investor webinars
06 May 2021 06:13 PM
RNS
Notice of AGM, Annual Report, Scrip Dividend
06 May 2021 05:55 PM
RNS
LTIP & DBSP awards; Director/PDMR shareholding
05 May 2021 07:00 AM
RNS
Portfolio company Inivata acquired by NeoGenomics
05 May 2021 07:00 AM
RNS
Portfolio company Kuur acquired by Athenex
04 May 2021 07:00 AM
RNS
Portfolio company Oxford Nanopore raises £195m
07 Apr 2021 11:27 AM
RNS
Director/PDMR Shareholding
30 Mar 2021 07:05 AM
RNS
Oxford Nanopore announces preparing for IPO in H2
26 Mar 2021 12:26 PM
RNS
EMA positive opinion for Diurnal's Chronocort
10 Mar 2021 07:00 AM
RNS
Annual Results
04 Mar 2021 06:07 PM
RNS
Holding(s) in Company
24 Feb 2021 10:33 AM
RNS
Notice of Results
17 Feb 2021 07:00 AM
RNS
Portfolio company ApcinteX acquired by Centessa
10 Feb 2021 07:00 AM
RNS
IP Group, Inc. raises $50.0m (£36.5m*) of funding
09 Feb 2021 03:52 PM
RNS
Holding(s) in Company
11 Jan 2021 05:29 PM
RNS
Holding(s) in Company
06 Jan 2021 04:57 PM
RNS
Portfolio co Hinge Health completes $300m round
06 Jan 2021 07:00 AM
RNS
Portfolio co Oxbotica completes £36m funding round
04 Dec 2020 11:41 AM
RNS
Holding(s) in Company
03 Dec 2020 08:01 AM
RNS
Artios and Merck in global strategic collaboration
25 Nov 2020 07:00 AM
RNS
Director Declaration
23 Nov 2020 05:05 PM
RNS
Holding(s) in Company
21 Oct 2020 07:00 AM
RNS
Investor webinar
13 Oct 2020 07:00 AM
RNS
Oxford Nanopore funding round and contract win
09 Oct 2020 09:46 AM
RNS
Oxford Nanopore's LamPORE test gains CE-IVD mark
07 Oct 2020 07:00 AM
RNS
Enterprise Therapeutics' program acquired by Roche
15 Sep 2020 12:07 PM
RNS
Second Price Monitoring Extn
15 Sep 2020 12:02 PM
RNS
Price Monitoring Extension
07 Sep 2020 12:07 PM
RNS
Second Price Monitoring Extn

IP Group plc is a British-based Intellectual property business investing in technology companies, based in London, England. It is listed on the London Stock Exchange since 2003 under the ticker IPO and is a constituent of the FTSE 250 Index.

The business was founded in 2001 and floated on the Alternative Investment Market in 2003 before achieving a full listing in 2006: it raised an additional £55m in June 2011. It acquired Fusion IP Group on 20 March 2014.

UK 100

Latest directors dealings